AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

IVA vs LTGO: stock comparison and AI forecast

Inventiva S.A. (IVA) and Latigo Biotherapeutics, Inc. (LTGO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

IVA Inventiva S.A.

Market Cap
$891M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

LTGO Latigo Biotherapeutics, Inc.

Market Cap
$863M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

IVA · LTGO

Key facts

  • IVA and LTGO have similar market capitalizations ($891M and $863M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIVALTGO
Market Cap$891M$863M
P/B Ratio–2.19x
Book Value/Share–$5.94
Revenue/Share$0.09–

Profitability & Margins

MetricIVALTGO
Operating Margin-1040.1%–
Net Margin-1034.0%–

Financial Health

MetricIVALTGO
Current Ratio–29.11x
D/E Ratio–0.04x
Financial Leverage–1.04x
Working Capital–$392M

Cash Flow

MetricIVALTGO
Operating Cash Flow-$182M–

Income Statement

MetricIVALTGO
Total Revenue$20M–
Operating Income-$210M–
Net Income-$209M–
R&D Expense$202M–

Dividend & Shareholder Information

MetricIVALTGO
Shares Outstanding245M66M
FAQ

IVA vs LTGO: stock comparison and AI forecast

Which is bigger, IVA or LTGO?

IVA and LTGO have similar market capitalizations ($891M and $863M).

Which one does Intratio's AI model rank higher, IVA or LTGO?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.